TIKOMED

tikomed-logo

They develop and commercialize innovative treatments for patients with severe and life-threatening conditions. Their products have the potential to improve outcomes in the treatment of neurological and opthalmic disease and for ground-breaking regenerative cell therapies. They give hope for patients lacking satisfactory alternatives.

#SimilarOrganizations #People #Website #More

TIKOMED

Social Links:

Industry:
Biotechnology Therapeutics

Founded:
2002-01-01

Address:
Viken, Skane Lan, Sweden

Country:
Sweden

Website Url:
http://www.tikomed.com

Total Employee:
11+

Status:
Active

Email Addresses:
news.ilb@tikomed.com

Total Funding:
13 M EUR

Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving SPF Apple Mobile Web Clips Icon Google Font API WordPress SSL By Default Font Awesome IPv6


Similar Organizations

cygnal-therapeutics-logo

Cygnal Therapeutics

Cygnal Therapeutics is a biotechnology company

excellthera-logo

ExCellThera

ExCellThera is an advanced clinical stage biotechnology company.

faze-medicines-logo

Faze Medicines

Faze Medicines is a biotechnology company.

immunicom-logo

Immunicom

Immunicom is a biotechnology company.

isarna-therapeutics-logo

Isarna Therapeutics

Isarna Therapeutics is a biotechnology company.

laxxon-medical-logo

Laxxon Medical

Laxxon Medical is a biotechnology company.

molmed-logo

MolMed

MolMed is a biotechnology company.

neomorph-logo

Neomorph

Neomorph is a biotechnology company.

themis-bioscience-logo

Themis Bioscience

Themis Bioscience is a start-up biotechnology company.

viromed-logo

ViroMed

ViroMed is a leading biotechnology company

Current Employees Featured

adam-bruce_image

Adam Bruce
Adam Bruce Founder and Bordmember @ TikoMed
Founder and Bordmember
2002-03-01

anders-kristensson_image

Anders Kristensson
Anders Kristensson CEO @ TikoMed
CEO
2018-06-01

Founder


adam-bruce_image

Adam Bruce

Official Site Inspections

http://www.tikomed.com Semrush global rank: 16.28 M Semrush visits lastest month: 1

  • Host name: molnet.portsit.se
  • IP address: 193.12.211.180
  • Location: Lerum Sweden
  • Latitude: 57.7705
  • Longitude: 12.269
  • Timezone: Europe/Stockholm
  • Postal: 443 50

Loading ...

More informations about "TikoMed"

Home - Tikomed

Developing game changing treatments and cell therapies for severe diseases Important message to ALS patients and healthcare professionals, who have enquiries about our drug candidate ILB® The articles published in the journal …See details»

The Company - tikomed.com

TikoMed AB is a privately owned company based in Viken, Sweden. It is governed by the Laws of the Kingdom of Sweden and was formed in accordance with the Swedish Company Act in …See details»

TikoMed - Crunchbase Company Profile & Funding

TikoMed closed its last funding round on Mar 13, 2020 from a Venture - Series Unknown round. Who are TikoMed 's competitors? Alternatives and possible competitors to TikoMed may …See details»

TikoMed AB - LinkedIn

TikoMed AB | 663 followers on LinkedIn. Developing game changing treatments and cell therapies for severe diseases. | We develop and commercialize innovative treatments for patients with severe ...See details»

Tikomed 2025 Company Profile: Valuation, Funding

Tikomed was founded in 2002. Where is Tikomed headquartered? Tikomed is headquartered in Viken, Sweden. What is the size of Tikomed? Tikomed has 8 total employees. What industry is Tikomed in? Tikomed’s primary industry is …See details»

Company Newsroom of TikoMed AB

TIKOMED, a specialty pharma company focused on developing therapeutics for treating acute and degenerative neurological and ophthalmic diseases (ILB® program) and an infusion …See details»

TikoMed AB (TikoMed AB) - 药物管线_专利_临床试验_投融营收_最 …

VIKEN, Sweden, Sept. 7, 2022 /PRNewswire/ -- TikoMed today announced the inclusion in bioRxiv* of an in vitro study examining the ability of the company's lead drug candidate ILB® …See details»

TikoMed AB - Drug pipelines, Patents, Clinical trials - Synapse

Adds further support for its broad-spectrum mechanism of action following other recent TBI, ALS and tropical virus studies VIKEN, Sweden, Sept. 13, 2022 /PRNewswire/ -- TikoMed today …See details»

TikoMed AB - VentureRadar

May 16, 2019 Similar Companies: Obsidian Therapeutics USA Privately Held Obsidian Therapeutics is a biotechnology company developing next-generation cell and gene therapies …See details»

TikoMed - Funding, Financials, Valuation & Investors - Crunchbase

How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Mar 13, 2020: Venture Round - …See details»

The Company – Old - tikomed.com

TikoMed AB is a privately owned company based in Viken, Sweden. It is governed by the Laws of the Kingdom of Sweden and was formed in accordance with the Swedish Company Act in …See details»

Tikomed

The post TikoMed announces the publication of results from an open-label, single arm, single center phase II trial carried out at the Queen Elizabeth Hospital, Birmingham, UK, by the …See details»

Tikomed Company Profile - Office Locations, Competitors ... - Craft

Tikomed is a company that develops treatments for patients with severe and life-threatening conditions. It focuses on neurological and opthalmic diseases as well as regenerative cell …See details»

TIKOMED and IQVIA announce a strategic collaboration for the ...

VIKEN, Sweden, May 5, 2022 /PRNewswire/ -- Today, Swedish biopharmaceutical company TikoMed AB and IQVIA announce a key strategic collaboration with the aim to accelerate the …See details»

Tikomed - ILB

ILB’s mechanism of action may either reduce the triggers that lead to cell death or prevent further pathology even if triggers are present. By addressing the underlying processes of disease, ILB …See details»

Funding to Boost Clinical Development of Investigational ALS...

Mar 27, 2020 The funding also will help develop Ibsolvmir, a therapy to increase the effectiveness of transplanting cells to treat patients with severe diabetes and chronic …See details»

ILB – Tikomed - ALS/MND

On 25 May 2022, researchers from TikoMed AB, Sweden, published a paper in PLOS ONE that showed ILB was safe and tolerable in people with MND, and suggested evidence of potential …See details»

Стоматология ТикоМед: профессионализм, качество, забота

Вы можете быть уверены в том, что получите профессиональную консультацию и эффективное ...See details»

TikoMed announces the publication of results from an open-label, …

Jul 22, 2024 TikoMed, Lars Bruce, responsible for of the ILB® program. news.ilb@tikomed.com. To the editors. About TikoMed. TikoMed is a Swedish, private company founded in 2002 by …See details»

Tikomed - Cision News

Tikomed is committed to improve human life by exploring and harnessing the medical potential of the body’s ability to self-repair and regenerate. With an adaptive, multi modal mechanism of …See details»

linkstock.net © 2022. All rights reserved